Sequencing of SLCO1B1, the gene encoding OATP1B1, identified genetic variants associated with a significant reduction in cerivastatin uptake in 122 patients who developed rhabdomyolysis while on cerivastatin. Here, SLCO1B1 is linked to rhabdomyolysis.